Font Size:
a
A
A
Keyword [nucleos(t)ide]
Result: 81 - 99 | Page: 5 of 5
81.
Elevated Expression Of Serum Soluble ST2 In Clinical Relapse After Stopping Long-term Nucleos(t)ide Analogue Therapy For Chronic Hepatitis B
82.
Analysis Of The Outcome And Influencing Factors Of Acute-on-chronic Liver Failure Of HBeAg Positive And Hbe Ag Negative Hepatitis B Patients Caused By Withdrawal Of Nucleos(t)ide Analogs
83.
Analysis Of Variation After Treatment With Nucleos(t) Ide Analogue In Patients With Chronic Hepatitis B
84.
Effects Of IFN Combined With Nas Therapy In HBeAg-positive Chronic Hepatitis B:A Meta-analysys
85.
Changes In HBsAg Quantification After HBV DNA Below The Lowest Limit Of Detection In Patients With Chronic Hepatitis B Treated With Nucleos(t)ide Analogues
86.
Study On The Efficacy And Evolutionary Patterns Of HBV In Patients With Chronic Hepatitis B During Nucleot(s)ide Analog Therapy
87.
Application Of Serum HBV RNA To Predict The Antiviral Response Of Nucleos(t)ide Analogues
88.
Long-term Outcomes Of Antiviral Therapy And Relationship Between Changes Of HBsAg Kinetics And Host Adaptive Immunity In Chronic Hepatitis B Patients
89.
Peg IFN-? Treatment Enhanced The Inhibitory Effect Of NK Cells On Treg In Nucleos(t)ide Analogues-treated Patients With Chronic Hepatitis B
90.
Treatment Efficacy And Related Factors Of Nucleos(t)ide Analogues In Patients With CHB And Related Liver Fibrosis
91.
The Early Impact Of Nucleos(t)ide Analogs On Kidneys In Patients With Chronic Hepatitis B
92.
The Expression And Clinical Significance Of Serum MiRNA-122 After Cessation Of Nucleos(t)ide Analogue Therapy For Chronic Hepatitis B.
93.
Characteristics And Related Factors For Chronic Hepatitis B Patients With Low-level Viremia After NAs Treatment ——A Single-center Cross-sectional Retrospective Study
94.
Correlation Between Serum HBV PgRNA And Antigen Status In Patients With Chronic Hepatitis B After Long-term Nucleotide Analogues Treatment
95.
Hepatitis B Surface Antigen Kinetics After Discontinuation Of Nucleos(t)ide Analogues Treatment In Non-cirrhotic HBeAg-positive Chronic Hepatitis B
96.
Analysis Of Early Renal Function Damage In Patients With Chronic Hepatitis B Treated With Nucleos(t)ide Analogues
97.
Clinical Study Of HbsAg Low-level Nucleoside (acid)analogues Treatment Of Chronic Hepatitis B Patients Combined With Long-acting Interferon Therapy
98.
The Expression Of Serum HBV PgRNA In Chronic Hepatitis B Patients Treated With NAs And Its Clinical Significance
99.
Analysis Of Clinical Characteristics Of 243 Cases Of Low Viremia Treated With NAs For Hepatitis B Cirrhosis
<<First
<Prev
Next>
Last>>
Jump to